| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Association Between Cardiovascular Health and Lifetime Risk of Heart Failure
|
Thangada, Neela D.
|
|
|
12 |
10 |
p. 1788-1790
|
artikel
|
| 2 |
Beyond Remodeling
|
Golino, Michele
|
|
|
12 |
10 |
p. 1800-1801
|
artikel
|
| 3 |
Combining Loop and Thiazide Diuretics Across the Left Ventricular Ejection Fraction Spectrum
|
Sánchez-Marteles, Marta
|
|
|
12 |
10 |
p. 1719-1730
|
artikel
|
| 4 |
Contemporary Patterns of Medicare and Medicaid Utilization and Associated Spending on Tafamidis in Cardiac Amyloidosis
|
Bansal, Kannu
|
|
|
12 |
10 |
p. 1791-1793
|
artikel
|
| 5 |
Controversies and Conundrums in Cardiac Cachexia
|
Ilonze, Onyedika J.
|
|
|
12 |
10 |
p. 1645-1660
|
artikel
|
| 6 |
Distinct Comorbidity Clusters in Patients With Acute Heart Failure
|
Gomez, Karla Arevalo
|
|
|
12 |
10 |
p. 1762-1774
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
12 |
10 |
p. A1-A6
|
artikel
|
| 8 |
Exciting Developments at JACC: Heart Failure
|
Bozkurt, Biykem
|
|
|
12 |
10 |
p. 1797-1799
|
artikel
|
| 9 |
Finding a Signal in the Noise
|
Deswal, Anita
|
|
|
12 |
10 |
p. 1775-1777
|
artikel
|
| 10 |
Full Issue PDF
|
|
|
|
12 |
10 |
p. i-CLXIV
|
artikel
|
| 11 |
Immune Checkpoint Inhibitors Myocarditis
|
Nikolova, Andriana P.
|
|
|
12 |
10 |
p. 1794-1796
|
artikel
|
| 12 |
Myocardial Mitochondrial Function Is Impaired in Cardiac Light-Chain Amyloidosis Compared to Transthyretin Amyloidosis
|
Voß, Fabian
|
|
|
12 |
10 |
p. 1778-1780
|
artikel
|
| 13 |
Obesity, Challenges, and Weight-Loss Strategies for Patients With Ventricular Assist Devices
|
daSilva-deAbreu, Adrian
|
|
|
12 |
10 |
p. 1661-1676
|
artikel
|
| 14 |
Optimizing Triage of Ambulatory Patients With Advanced Heart Failure
|
Aaronson, Keith D.
|
|
|
12 |
10 |
p. 1734-1746
|
artikel
|
| 15 |
Randomized Trial of Cholesterol Lowering With Evolocumab for Cardiac Allograft Vasculopathy in Heart Transplant Recipients
|
Broch, Kaspar
|
|
|
12 |
10 |
p. 1677-1688
|
artikel
|
| 16 |
Reply
|
Carberry, Jaclyn
|
|
|
12 |
10 |
p. 1802
|
artikel
|
| 17 |
Sacubitril/Valsartan in Heart Failure and Deterioration in eGFR
|
Jefferies, John L.
|
|
|
12 |
10 |
p. 1704-1706
|
artikel
|
| 18 |
Sacubitril/Valsartan in Patients With Heart Failure and Deterioration in eGFR to <30 mL/min/1.73 m2
|
Chatur, Safia
|
|
|
12 |
10 |
p. 1692-1703
|
artikel
|
| 19 |
Simplifying Treatment of Congestion
|
Boorsma, Eva M.
|
|
|
12 |
10 |
p. 1731-1733
|
artikel
|
| 20 |
Sodium Zirconium Cyclosilicate in HFrEF and Hyperkalemia
|
Kosiborod, Mikhail N.
|
|
|
12 |
10 |
p. 1707-1716
|
artikel
|
| 21 |
The EVOLVeD Role of Cholesterol-Lowering Therapies in Cardiac Allograft Vasculopathy
|
Nikolova, Andriana P.
|
|
|
12 |
10 |
p. 1689-1691
|
artikel
|
| 22 |
The Pathophysiological and Therapeutic Implications of Cardiac Light-Chain Amyloidosis Compared With Transthyretin Amyloidosis
|
Schilling, Joel D.
|
|
|
12 |
10 |
p. 1781-1787
|
artikel
|
| 23 |
Therapeutic Options in Ambulatory Advanced Heart Failure
|
Dunlay, Shannon M.
|
|
|
12 |
10 |
p. 1747-1749
|
artikel
|
| 24 |
The Role of Sodium Zirconium Cyclosilicate in Optimizing Heart Failure Therapy
|
Rakisheva, Amina
|
|
|
12 |
10 |
p. 1717-1718
|
artikel
|
| 25 |
Vericiguat and Cardiovascular Outcomes in Heart Failure by Baseline Diabetes Status
|
Khan, Muhammad Shahzeb
|
|
|
12 |
10 |
p. 1750-1759
|
artikel
|
| 26 |
Vericiguat, Diabetes, and Heart Failure
|
Scirica, Benjamin M.
|
|
|
12 |
10 |
p. 1760-1761
|
artikel
|
Tijdschrift beschrijving